Blueprint MedicinesBPMC 
$89.313.24%24h
3.24%24h
Global rank2611
Market cap$5.41B
Change 7d3.49%
YTD Performance-1.36%
SP500 benchmarkUnderperform
P/E-10.67
P/S21.69
Revenue$249.38M
Earnings-$506.98M
Dividend yield-
Main Sector
Healthcare
Blueprint Medicines Revenue data
According to Blueprint Medicines latest financial reports the company had revenue of $249.38M in 2023-12-31, a 22.22% increase from 2022. Blueprint Medicines highest revenue was $793.74M in 2020.
Revenue history for Blueprint Medicines from 2020 to 2024
-
Value:-
Blueprint Medicines revenue by year
| Year | Revenue | Change |
|---|---|---|
| 2023 | $249.38M | 22.22% |
| 2022 | $204.04M | 13.30% |
| 2021 | $180.08M | -77.31% |
| 2020 | $793.74M | - |
View the top revenue stocks 
